Michael Platten

Company: TcellTech and German Cancer Research Center

Job title: Founder & Managing Director

Seminars:

Safeguarding Therapeutic Precision: Mitigating Toxicity in TCR-T Therapy 1:30 pm

• predicTCR – a machine learning classifier for rapid, scRNAseq- based identification of tumor-reactive T-cell receptors for personalised T-cell therapy • Discuss strategies to identify patient-specific tumor-reactive TCRs for personalized T cell therapy • Manufacturing personalized TCR-transgenic T-cells: explore methodologies ensuring clinically viable turnaround times • Regulatory challenges: discuss potential solutions for implementing perosnalized TCRtransgenic…Read more

day: Conference Day Two

Safeguarding Therapeutic Precision: Mitigating Toxicity in TCR-T Therapy 1:30 pm

predicTCR – a machine learning classifier for rapid, scRNAseq-based identification of tumor-reactive T-cell receptors for personalised T-cell therapy Discuss strategies to identify patient-specific tumor-reactive TCRs for personalized T cell therapy Manufacturing personalized TCR-transgenic T-cells: explore methodologies ensuring clinically viable turnaround times Regulatory challenges: discuss potential solutions for implementing perosnalized TCR-transgenic T-cell therapiesRead more

day: DAY TWO TRACK 2 B